Back

GLP-1 agonists: how do they work? - discussion

26 August 2023 (11:35 - 11:40)
Organised by: Logo
Congress Presentation Part of: Pharma Made Easy Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

5 More presentations in this session

Presentation thumbnail
Lipid lowering agents: how to make optimal use of the full spectrum
Professor F. Mach (Geneva, CH)
Slides
Presentation thumbnail
Lipid lowering agents: how to make optimal use of the full spectrum - discussion
Presentation thumbnail
GLP-1 agonists: how do they work?
Professor U. Laufs (Leipzig, DE)
Slides
Presentation thumbnail
Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors
Professor S. Massberg (Munich, DE)
Slides
Presentation thumbnail
Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors - discussion

Access the full session

Session thumbnail
Pharma Made Easy

The Event

Event poster

ESC Congress 2023

26 August 2023 11:35 CET
You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?
24 November 2025
thumbnail
Congress Presentation
Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study
31 August 2024
thumbnail
Congress Presentation
GLP1-RA associated with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences
20 June 2025
thumbnail
Congress Presentation
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources